Earlier this week, Neil Woodford raised a record £800 million for his latest investment trust, the Woodford Patient Capital trust, which will invest in early stage businesses and scientific IP emerging from British universities – including biotechnology.

It’s launch on the London Stock Exchange on Tuesday was the largest of any UK-based listed fund, and it now sits within the FTSE 250 index – a great boost for the industry.

Today’s sector video features an interview with Neil Woodford, from the Telegraph, discussing the prospect of a biotech bubble – with thoughts on the US and the UK markets.


Do you have a video you would like the sector to see? Contact us.